Publication | Open Access
Analysis of POLE mutation and tumor mutational burden (TMB) across 80,853 tumors: Implications for immune checkpoint inhibitors (ICPIs)
14
Citations
0
References
2017
Year
Tumor Mutational BurdenTumor HeterogeneityMedicineImmune Checkpoint InhibitorsPole MutationImmunologyPathologyImmune Checkpoint InhibitorCancer GeneticsImmunotherapyOncologyTumor Biology
No additional data available for this publication yet. Check back later!